Skip to main content
ACG 2023 Annual Meeting Main banner
Back

Oral Paper Presentation

Annual Scientific Meeting
Paper/Abstract Presentations

Plenary Session 2B - Small Intestine / IBD

Tuesday, October 24, 2023
8:30 AM – 10:00 AM PT
Location: Ballroom B

Livestream

Presentations:

  • 8:30 AM – 8:40 AM PT
    Patterns in Follow-Up Testing for Individuals Newly Positive for Celiac Disease Antibodies

    Presenting Author: James King, MSc(Epi) – University of Calgary

  • 8:40 AM – 8:50 AM PT
    Women’s Health Disorders in a Celiac Disease Population- A Nationwide Cohort Analysis

    Presenting Author: Rama Nanah, MD – Cleveland Clinic

  • 8:50 AM – 9:00 AM PT
    The Effect of Low-Dose Aspirin on Disease Activity in Pregnant Individuals with Inflammatory Bowel Disease

    Presenting Author: Uma Mahadevan, MD, FACG – University of California

  • 9:00 AM – 9:10 AM PT
    Increased Risk of Respiratory Syncytial Virus Among Patients With Inflammatory Bowel Disease

    Presenting Author: Ryan A. Smith, MD (he/him/his) – University of Wisconsin Hospitals and Clinics

  • 9:10 AM – 9:20 AM PT
    Pharmacokinetics, Exposure-Response Relationships, and Immunogenicity in Crohn’s Disease Patients with Ustekinumab Secondary Loss of Response Following Ustekinumab IV Re-Induction: Week 16 Results from the POWER Study

    Presenting Author: Brian G. Feagan, MD – Western University

  • 9:20 AM – 9:30 AM PT
    Symptomatic Improvement Observed Within 2 Days of Etrasimod Induction Therapy: Results from ELEVATE UC 52 and ELEVATE UC 12 Studies in Patients with Ulcerative Colitis

    Presenting Author: Marla C. Dubinsky, MD – Mount Sinai Kravis Children’s Hospital

  • 9:30 AM – 9:40 AM PT
    Early Symptomatic Improvement With Guselkumab Induction Treatment in Moderately to Severely Active Ulcerative Colitis: Results from the Phase 3 QUASAR Induction Study

    Presenting Author: Gary Lichtenstein, MD – University of Pennsylvania

  • 9:40 AM – 9:50 AM PT
    Risankizumab Induction Therapy in Patients WIth Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study

    Presenting Author: Edward V. Loftus, Jr., MD, FACG – Division of Gastroenterology and Hepatology, Mayo Clinic

  • 9:50 AM – 10:00 AM PT
    Monitoring IBD by Intestinal Ultrasound Decreases Time to Treatment Change and Time to Remission in Comparison to Conventional Management

    Presenting Author: Noa Krugliak Cleveland, MD (she/her/hers) – University of Chicago Medicine, Inflammatory Bowel Disease Center